popul
hepat
b
combin
number
metabol
disord
increas
significantli
resveratrol
rsv
use
preclin
drug
treatment
metabol
disord
howev
impact
rsv
hbv
replic
remain
unknown
studi
hbvexpress
hepatocelluar
carcinoma
cell
line
mous
model
creat
hydrodynam
inject
viral
dna
use
found
rsv
activ
turn
deacetyl
subsequ
increas
transcript
activ
lead
enhanc
hbv
transcript
replic
vitro
vivo
addit
found
pathway
also
requir
fastinginduc
hbv
transcript
taken
togeth
studi
identifi
rsv
enhanc
hbv
transcript
replic
especi
act
core
promot
depend
pathway
conclud
rsv
may
exacerb
progress
hepat
b
patient
hepat
b
infect
cautiou
take
rsv
dietari
supplement
hepat
b
viru
hbv
small
envelop
dna
viru
chronic
infect
million
peopl
worldwid
caus
million
peopl
death
per
year
due
hbvassoci
liver
patholog
current
firstlin
drug
hbv
treatment
includ
interferon
nucleosid
nucleotid
analogu
drug
minim
hbv
replic
unabl
cure
hepat
b
therefor
protect
hbv
patient
recur
high
hbv
dna
level
minim
liver
damag
still
one
import
strategi
manag
infecti
diseas
increas
evid
show
result
sedentari
behavior
poor
dietari
choic
peopl
suffer
metabol
syndrom
correl
increas
risk
diabet
cardiovascular
diseas
stroke
hbv
patient
also
subject
metabol
disord
present
preval
combin
metabol
syndrom
chronic
hbv
infect
gener
popul
around
although
interact
chronic
hepat
b
metabol
diseas
controversi
presenc
chronic
hbv
infect
metabol
syndrom
increas
risk
cirrhosi
hepatocellular
carcinoma
hcc
resveratrol
rsv
polyphenol
found
varieti
plant
speci
rsv
shown
exert
benefici
effect
across
speci
variou
diseas
model
prevent
slow
progress
varieti
ill
especi
metabol
diseas
recent
shown
rsv
impact
variou
viral
infect
via
differ
pathway
instanc
rsv
shown
antagon
respiratori
syncyti
viru
infect
lung
via
inhibit
complex
rsv
also
found
effect
treat
influenza
viru
sever
acut
respiratori
syndrom
sar
rsv
also
shown
synerg
sever
antiretrovir
drug
treatment
human
immunodefici
viru
hiv
herp
simplex
virus
hsv
vivo
studi
rsv
cream
achiev
efficaci
treatment
skin
lesion
abrad
epidermi
mice
acyclovir
cream
addit
rsv
confirm
enhanc
replic
hepat
c
viru
indic
rsv
suitabl
antioxid
therapi
chronic
hepat
c
howev
effect
rsv
hepat
b
viru
remain
unclear
studi
investig
role
rsv
regul
hbv
replic
surprisingli
found
rsv
administr
dramat
upregul
hbv
dna
product
hbvexpress
cell
mous
model
via
activ
pathway
first
test
toxic
rsv
cell
determin
optim
dose
later
treatment
inhibitori
concentr
cell
viabil
rsv
treatment
effect
concentr
chosen
follow
experi
rsv
fig
explor
impact
rsv
hbv
replic
cell
equival
number
cell
expos
rsv
control
vehicl
hour
hbv
dna
cultur
medium
measur
realtim
qpcr
found
rsv
treatment
dosedepend
upregul
hbv
dna
level
nearli
time
higher
control
fig
result
obtain
data
show
cell
transient
transfect
hbv
genom
dna
fig
establish
hbv
replic
mous
model
hydrodynam
inject
hbv
genom
dna
mous
accord
previou
studi
inject
serum
hbv
dna
number
mice
remain
low
level
iuml
one
month
fig
consist
previou
data
treatment
rsv
mgkgd
via
daili
oral
gavag
rsv
week
serum
hbv
dna
level
significantli
increas
maintain
higher
level
toward
end
point
drug
administr
fig
suggest
rsv
strong
stimul
hbv
dna
replic
rsv
activ
hbv
core
promot
investig
mechan
rsv
upregul
hbv
replic
measur
pregenom
rna
pgrna
prec
rna
cell
realtim
qpcr
hbcag
express
western
blot
hbsag
hbeag
content
releas
cultur
medium
elisa
found
rsv
treatment
increas
pgrna
prec
rna
level
almost
respect
also
hbeag
hbcag
level
nearli
respect
slight
increas
hbsag
express
fig
suggest
transcript
hbv
dna
activ
rsv
treatment
especi
region
viral
core
promot
vivo
experi
support
observ
rsv
treatment
mgkgd
week
increas
hbsag
hbeag
level
circul
fig
c
indic
viral
core
promot
play
key
role
process
measur
activ
core
promot
respect
cell
found
rsv
treatment
increas
core
promot
activ
nearli
activ
promot
much
less
potenc
fig
confirm
result
vivo
hbvcpluc
plasmid
dna
hydromat
inject
mice
hour
later
mice
treat
rsv
minut
activ
core
promot
mice
liver
measur
anim
imag
system
real
time
found
rsv
increas
luciferas
signal
liver
nearli
compar
vehicl
control
fig
result
suggest
rsv
promot
hbv
replic
activ
hbv
core
promot
vivo
luciferas
analysi
mice
observ
administr
water
control
group
nc
rsv
experiment
group
exp
repres
imag
visual
luciferas
activ
left
quantit
analysi
data
right
shown
gel
run
experiment
condit
p
n
group
identifi
transcript
factor
involv
activ
core
promot
rsv
knock
variou
hbvrelat
transcript
factor
includ
jun
protooncogen
cjun
peroxisom
proliferatoractiv
receptor
alpharetinoid
x
receptor
alpha
ccaatenhanc
bind
protein
cebp
alpha
farnesoid
x
activ
receptor
hepatocyt
nuclear
factor
alpha
cell
small
interf
rna
sirna
realtim
qpcr
data
demonstr
knockdown
abolish
rsvinduc
hbv
replic
fig
knockdown
other
nt
affect
supernat
hbv
dna
level
fig
examin
whether
could
regul
hbv
core
promot
knock
sirna
cell
follow
transfect
rsv
treatment
evid
knockdown
either
ppar
rxr
reduc
luciferas
signal
core
promot
fig
evalu
activ
affect
rsv
treatment
measur
express
target
gene
rtqpcr
cell
mous
liver
rsv
stimul
express
target
gene
promot
fatti
acid
oxid
fao
key
mitochondri
medium
chain
acylcoa
dehydrogenas
mcad
microsom
cytochrom
fao
mitochondri
synthas
mhmgcoa
ketogenesi
fig
taken
togeth
activ
core
promot
play
key
role
rsvinduc
hbv
transcript
requir
rsvinduc
hbv
replic
rsv
act
posit
regul
sirtuin
improv
metabol
process
age
hepat
steatosi
diabet
examin
whether
also
involv
rsvinduc
hbv
replic
measur
express
endogen
well
activ
cell
mous
liver
found
rsv
increas
mrna
protein
level
fig
b
also
enhanc
ratio
nadnadh
fig
consist
previou
report
examin
whether
contribut
rsvinduc
hbv
replic
measur
hbv
dna
cultur
media
knockdown
cell
fig
knockdown
significantli
decreas
hbv
dna
level
almost
compar
control
fig
activ
hbv
core
promot
rsv
also
substanti
block
knockdown
fig
addit
nicotinamid
nam
activ
inhibitor
also
dramat
reduc
rsvstimul
hbv
core
promot
activ
fig
data
demonstr
essenti
role
rsvstimul
hbv
replic
previou
studi
demonstr
hepat
lipid
metabol
activ
via
deacetyl
peroxisom
proliferatoractiv
receptor
gamma
coactiv
alpha
analyz
whether
signal
link
rsvinduc
hbv
replic
examin
acetyl
cell
rsv
treatment
significantli
decreas
acetyl
level
protein
cell
fig
increas
interact
endogen
fig
pretreat
nicotinamid
nam
activ
inhibitor
restor
acetyl
level
untreat
group
fig
determin
whether
requir
rsvinduc
hbv
replic
knock
sirna
cell
defici
caus
signific
decreas
hbv
dna
cultur
medium
compar
control
fig
similarli
knockdown
significantli
reduc
rsvstimul
core
promot
activ
cell
fig
sum
find
indic
activ
rsv
directli
regul
acetyl
result
rsvinduc
hbv
replic
activ
requir
fastinginduc
hbv
replic
calori
restrict
similar
effect
energi
metabol
rsv
treatment
report
fast
induc
hbv
gene
express
given
fact
transcript
activ
activ
fast
essenti
role
axi
mediat
rsvinduc
hbv
replic
reckon
may
requir
fastingtrigg
hbv
replic
test
idea
mice
starv
differ
time
period
inject
hbvcpluc
plasmid
dna
core
promot
activ
assess
luciferas
intens
timedepend
increas
fast
mice
fig
e
verifi
role
g
antagonist
nam
markedli
block
rsvstimul
activ
viral
core
promot
cell
cotransfect
prltk
plasmid
hour
cell
treat
rsv
rsv
plu
nam
mm
h
gel
run
experiment
condit
experi
repeat
least
three
time
consist
result
bar
graph
repres
mean
sem
n
p
process
hepat
express
target
gene
includ
mcad
cytochrom
mhmgcoa
measur
rtqpcr
starvat
upregul
mrna
level
gene
measur
fig
similar
caus
rsv
treatment
fig
addit
specif
inhibitor
significantli
block
enhanc
activ
hbv
core
promot
fast
time
cours
starvat
fig
e
suggest
essenti
role
activ
fastinginduc
hbv
transcript
rsv
attract
tremend
attent
past
year
due
benefici
effect
number
diseas
eg
metabol
cardiovascular
diseas
age
cancer
exert
protect
function
antioxid
properti
antiinflammatori
antiprolif
function
respect
although
rsv
found
effect
sever
viral
infect
studi
first
time
demonstr
rsv
actual
induc
hbv
replic
vitro
vivo
given
fact
increas
success
case
preclin
trial
rsv
treatment
varieti
human
diseas
data
rais
seriou
concern
risk
possibl
side
effect
rsv
treatment
rsv
patient
metabol
disord
simultan
infect
hbv
addit
rsv
exist
number
fruit
red
grape
mgg
drink
red
wine
mgl
mgl
notabl
concentr
patient
hbv
infect
especi
hbv
carrier
occult
infect
patient
would
risk
hbv
recurr
drink
overdos
red
wine
given
drink
cultur
larg
popul
worldwid
addit
studi
would
requir
determin
guidelin
amount
red
wine
drink
hbv
patient
data
consist
previou
find
rsv
consid
activ
member
mammalian
sirtuin
hdac
class
iii
ren
discrep
two
studi
discuss
may
partial
due
differ
cell
model
experiment
condit
use
studi
unlik
rsv
alon
display
strong
abil
promot
hbv
replic
depend
manner
protein
appear
constitut
subnetwork
modul
hbv
core
promot
activ
viral
transcript
rsvinduc
activ
mediat
hbv
transcript
inhibit
nam
attenu
effect
suggest
activ
requir
rsvinduc
hbv
replic
given
limit
effect
overexpress
activ
hbv
transcript
like
explan
rsv
independ
function
simultan
activ
signal
augment
function
subnetwork
activ
pathway
fast
induc
metabol
respons
allow
mammal
surviv
long
period
energi
depriv
dramat
chang
gluconeogenesi
fatti
acid
oxid
promin
featur
energymetabol
respons
shlomai
et
al
demonstr
control
hbv
replic
nutrit
signal
interestingli
coactiv
key
enzym
gluconeogenesi
promot
hbv
replic
howev
think
role
conclus
due
lack
loss
function
studi
demonstr
necess
process
studi
although
express
gluconeugen
gene
upregul
fast
similar
chang
gene
express
time
point
prolong
fast
fig
suggest
activ
gluconeogenesi
associ
fastinginduc
hbv
viral
replic
instead
found
gene
involv
fao
close
associ
fastinginduc
hbv
transcript
replic
confirm
experi
inhibit
key
enzym
fao
allevi
fastinginduc
hbv
transcript
vivo
provid
strong
evid
fao
play
import
role
hbv
replic
host
expos
nutrientenergi
defici
summari
studi
demonstr
rsv
strong
abil
enhanc
hbv
replic
core
promot
shown
fig
rsv
activ
enhanc
hbv
replic
depend
mechan
resembl
pathway
fastinginduc
fao
hbv
replic
supplement
hbv
patient
rsv
present
potenti
risk
hepat
b
recurr
anim
studi
conduct
strict
accord
recommend
guid
care
use
laboratori
anim
accord
regul
peopl
republ
china
protocol
approv
committe
ethic
anim
experi
zhejiang
univers
approv
procedur
made
minim
suffer
mice
male
week
old
obtain
shanghai
laboratori
anim
center
shanghai
china
use
anim
experi
whole
hbv
analysi
ten
microgram
hbv
plasmid
dna
phbv
volum
pb
equival
mous
bodi
weight
inject
via
tail
vein
day
accord
method
twenti
eight
day
hydrodynam
inject
mice
divid
two
group
follow
rsv
group
group
mice
receiv
either
rsv
mgkg
mous
bodi
weight
vehicl
water
oral
gavag
everi
day
week
chosen
dose
base
previou
studi
rsv
resuspend
water
mice
sacrif
day
inject
liver
tissu
sera
collect
patholog
biochem
analysi
anim
imag
experi
mice
inject
six
microgram
hbvcpluc
construct
analysi
perform
h
hydrodynam
inject
mice
receiv
intragastr
administr
rsv
mgkgd
vehicl
water
minut
mice
anesthet
isofluran
dluciferin
potassium
salt
perkin
elmer
usa
mgkg
intraperiton
inject
ip
inject
visual
luciferas
activ
perform
lumazon
equip
nippon
roper
japan
data
analysi
includ
quantif
perform
use
slidebook
softwar
intellig
imag
innov
usa
luciferas
activ
everi
anim
quantifi
express
ratio
rel
baselin
activ
starvat
experi
male
litterm
separ
individu
cage
begin
fast
experi
fast
initi
pm
mice
inject
hbvcpluc
plasmid
h
prior
fast
divid
two
group
experiment
group
n
fast
free
access
water
allow
indic
time
h
allow
subsequ
refeed
control
group
n
let
continu
free
feed
luciferas
activ
core
promot
visual
indic
time
meanwhil
anoth
mice
divid
group
h
fast
h
fast
h
fast
h
refe
n
treat
indic
kill
liver
tissu
collect
immedi
frozen
liquid
nitrogen
analysi
investig
effect
inhibit
activ
viral
core
promot
nutrit
depriv
mice
hbvcpluc
plasmid
administ
acut
intraperiton
inject
mgkg
antagonist
min
prior
defin
fast
time
point
dose
chosen
base
previou
pilot
studi
control
anim
receiv
volum
vehicl
aqueou
solut
dmso
luciferas
activ
everi
anim
quantifi
time
point
plasmid
reagent
antibodi
hbvcpluc
gutless
hbv
construct
contain
luciferas
orf
hbv
core
promot
gift
yosef
shaul
depart
molecular
genet
weizmann
institut
scienc
rehovot
israel
plasmid
hbv
genom
dna
genebank
hbv
phbv
luciferas
report
vector
contain
hbv
core
promot
nt
promot
nt
promot
respect
construct
laboratori
accord
standard
procedur
describ
resveratrol
sigma
usa
nicotinamid
sigma
usa
sigma
usa
trichostatin
sigma
usa
purchas
sigma
sirna
silenc
cjun
ppara
scrambl
sirna
purchas
ribobio
guangzhou
china
sirna
sequenc
list
tabl
tabl
detect
pgrna
prec
rna
primer
use
base
previou
pilot
studi
brief
cdna
product
use
three
separ
amplif
reaction
ggaaagaagt
cagaaggcaa
common
antisens
primer
sens
primer
pcp
ggtctgcgcaccagcacc
specif
detect
prec
rna
transcript
pgp
cacctctgcctaatcatc
monitor
total
cpdirect
rna
transcript
pgrna
plu
prec
rna
ctgggaggagttggggg
aggagatt
detect
residu
hbv
dna
contamin
level
pgrna
transcript
calcul
subtract
prec
rna
level
total
cpdirect
transcript
cell
examin
coimmunoprecipit
experi
use
antibodi
cell
lyse
cell
lysi
buffer
cell
signal
technolog
usa
contain
mm
pmsf
mm
nicotinamid
tsa
lysat
centrifug
min
supernat
use
immunoprecipit
fresh
protein
g
magnet
bead
millipor
usa
ad
incub
minut
continu
mix
room
temperatur
cell
lysat
sampl
immobil
captur
antibodi
incub
continu
mix
overnight
immunocomplex
wash
sever
time
denatur
laemmli
sampl
buffer
min
analyz
western
blot
immunoprecipit
separ
sdspage
immunoblot
use
antibodi
western
blot
perform
follow
briefli
equal
amount
protein
extract
denatur
separ
nupag
bistri
gel
transfer
pvdf
membran
afterward
membran
primer
name
gene
id
forward
primer
f
revers
primer
r
block
tbst
mm
nacl
mm
trishcl
ph
tween
contain
wv
nonfat
dri
milk
incub
correspond
primari
secondari
antibodi
indic
dilut
actin
gapdh
hbcag
acetylatedlysin
specif
band
visual
use
ecl
detect
kit
chemiscop
mini
equip
clinx
shanghai
china
protein
level
quantifi
use
imag
j
softwar
version
nih
imag
http
rsbinfonihgovij
follow
western
blot
use
antiacetyllysin
antibodi
acetyl
level
assay
use
specif
antibodi
acetyllysin
luciferas
ashsay
cell
plate
contain
cell
transient
transfect
report
vector
use
lipofectamin
accord
manufactur
instruct
transfect
mixtur
well
compris
ng
promot
report
plasmid
ng
plasmid
prltk
serv
intern
control
normal
transfect
effici
six
hour
transfect
rsv
ad
medium
indic
cell
incub
day
firefli
renilla
luciferas
activ
measur
use
dualglo
luciferas
assay
system
kit
promega
usa
accord
manufactur
instruct
luciferas
activ
determin
glomax
micropl
luminomet
promega
usa
nadnadh
ratio
assay
cell
grown
confluenc
cm
tissu
cultur
plate
cell
subsequ
treat
media
contain
dmso
rsv
hour
treatment
cell
lift
trypsin
wash
twice
cold
pb
pellet
centrifug
nad
nadh
ratio
perform
use
enzychrom
nadnadh
assay
kit
bioassay
system
usa
nad
nadh
content
normal
protein
concentr
cell
lysat
detect
serum
hbv
antigen
dna
serum
hbsag
hbeag
level
detect
automat
abbott
use
architect
hbsag
hbeag
reagent
kit
abbott
diagnost
abbott
park
il
usa
serum
hbv
dna
copi
measur
use
fluoresc
quantit
pcr
detect
kit
hepat
b
viru
dna
acon
biotech
co
ltd
hangzhou
china
hbsag
hbeag
hbv
dna
cultur
medium
measur
similarli
assay
conduct
follow
manufactur
instruct
statist
data
analyz
use
graphpad
prism
graphpad
softwar
inc
sandiego
usa
data
present
mean
sem
statist
signific
differ
determin
use
student
test
differ
consid
signific
p
